Company: PTPI
Filing Date: 2025-03-14
Form Type: PRER14A
Source: 0001104659-25-024012
Chunk: 88

Company: Petros Pharmaceuticals, Inc.
Filing Date: 2025-03-14
Form: PRER14A
Chunk 88
---
 or a subsidiary against any and all liabilities or expenses to which they may be subjected by reason of any
act or failure to act with respect to their duties on behalf of the Plan, except in circumstances involving such person’s bad faith
or willful misconduct.

Section 3. Awards

Awards under the Plan may consist of Options as
described in Section 6, Stock Awards as described in Section 7, Stock Units as described in Section 8, SARs as described
in Section 9 and Other Stock-Based Awards as described in Section 10. All Awards shall be subject to the terms and conditions
set forth herein and to such other terms and conditions consistent with this Plan as the Committee deems appropriate and as are specified
in writing by the Committee to an individual in an Award Agreement. All Awards shall be made conditional upon the Participant’s
acknowledgement, in writing or by acceptance of the Award, that all decisions and determinations of the Committee shall be final, conclusive
and binding on the Participant, his or her beneficiaries and any other person having or claiming an interest under such Award. Awards
under a particular Section of the Plan need not be uniform as among the Participants. Notwithstanding anything to the contrary herein,
any dividends or Dividend Equivalents granted in connection with Awards under the Plan shall vest and be paid only if and to the extent
the underlying Awards vest and are paid.

Section 4. Shares Subject to the Plan

(a) . Subject to adjustment as described below in Sections 4(b) and 4(e), the maximum aggregate number of shares
of Common Stock that may be issued or transferred under the Plan with respect to Awards made on and after the Effective Date shall be
2,600,000 shares. In addition, and subject to adjustment as described below in Sections 4(b) and 4(e), shares of Common Stock
subject to outstanding Awards granted under the Plan before the Effective Date and shares of Common Stock subject to outstanding grants
under the Prior Plans that terminate, expire or are cancelled, forfeited, exchanged or surrendered without having been exercised, vested
or paid in shares after the Effective Date shall be added to the shares reserved under the Plan. The aggregate number of shares of Common
Stock that may be issued or transferred under the Plan pursuant to Incentive Stock Options granted on and after the Effective Date shall
not exceed 2,600,000 shares of Common Stock.

(b) . Shares issued or transferred under the Plan may be authorized but un